These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17164260)

  • 21. ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy.
    Paglia LL; Laugé A; Weber J; Champ J; Cavaciuti E; Russo A; Viovy JL; Stoppa-Lyonnet D
    Breast Cancer Res Treat; 2010 Jan; 119(2):443-52. PubMed ID: 19404735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A putative "hepitype" in the ATM gene associated with chronic lymphocytic leukemia risk.
    Martín-Guerrero I; Enjuanes A; Richter J; Ammerpohl O; Colomer D; Ardanaz M; Marco F; Salas A; Campo E; Siebert R; García-Orad A
    Genes Chromosomes Cancer; 2011 Nov; 50(11):887-95. PubMed ID: 21910157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IVS10-6T>G, an ancient ATM germline mutation linked with breast cancer.
    Broeks A; Urbanus JH; de Knijff P; Devilee P; Nicke M; Klöpper K; Dörk T; Floore AN; van't Veer LJ
    Hum Mutat; 2003 May; 21(5):521-8. PubMed ID: 12673794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleotide excision repair genotype and the incidence of endometrial cancer: effect of other risk factors on the association.
    Weiss JM; Weiss NS; Ulrich CM; Doherty JA; Chen C
    Gynecol Oncol; 2006 Dec; 103(3):891-6. PubMed ID: 16806437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
    Sprague BL; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM
    Carcinogenesis; 2007 Aug; 28(8):1680-6. PubMed ID: 17449902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer.
    Roh JW; Kim JW; Park NH; Song YS; Park IA; Park SY; Kang SB; Lee HP
    Gynecol Oncol; 2004 May; 93(2):499-505. PubMed ID: 15099969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic variants in MGMT and risk of lung cancer in Southeastern Chinese: a haplotype-based analysis.
    Hu Z; Wang H; Shao M; Jin G; Sun W; Wang Y; Liu H; Wang Y; Ma H; Qian J; Jin L; Wei Q; Lu D; Huang W; Shen H
    Hum Mutat; 2007 May; 28(5):431-40. PubMed ID: 17285603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of P53 and ATM polymorphisms with risk of radiation-induced pneumonitis in lung cancer patients treated with radiotherapy.
    Yang M; Zhang L; Bi N; Ji W; Tan W; Zhao L; Yu D; Wu C; Wang L; Lin D
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1402-7. PubMed ID: 20729006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic.
    Polakova V; Pardini B; Naccarati A; Landi S; Slyskova J; Novotny J; Vodickova L; Bermejo JL; Hanova M; Smerhovsky Z; Tulupova E; Kumar R; Hemminki K; Vodicka P
    Hum Mutat; 2009 Apr; 30(4):661-8. PubMed ID: 19224585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort.
    Haiman CA; Stram DO; Pike MC; Kolonel LN; Burtt NP; Altshuler D; Hirschhorn J; Henderson BE
    Hum Mol Genet; 2003 Oct; 12(20):2679-92. PubMed ID: 12944421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ATM allelic variants associated to hereditary breast cancer in 94 Chilean women: susceptibility or ethnic influences?
    Tapia T; Sanchez A; Vallejos M; Alvarez C; Moraga M; Smalley S; Camus M; Alvarez M; Carvallo P
    Breast Cancer Res Treat; 2008 Jan; 107(2):281-8. PubMed ID: 17351744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ATM missense variant P1054R predisposes to prostate cancer.
    Meyer A; Wilhelm B; Dörk T; Bremer M; Baumann R; Karstens JH; Machtens S
    Radiother Oncol; 2007 Jun; 83(3):283-8. PubMed ID: 17502119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Common ataxia telangiectasia mutated haplotypes and risk of breast cancer: a nested case-control study.
    Tamimi RM; Hankinson SE; Spiegelman D; Kraft P; Colditz GA; Hunter DJ
    Breast Cancer Res; 2004; 6(4):R416-22. PubMed ID: 15217510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovering moderate-risk breast cancer susceptibility genes.
    Hollestelle A; Wasielewski M; Martens JW; Schutte M
    Curr Opin Genet Dev; 2010 Jun; 20(3):268-76. PubMed ID: 20346647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epistatic relationship between the cancer susceptibility genes CHEK2 and p27.
    Cybulski C; Gliniewicz B; Sikorski A; Kładny J; Huzarski T; Gronwald J; Byrski T; Debniak T; Gorski B; Jakubowska A; Wokolorczyk D; Narod SA; Lubiñski J
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):572-6. PubMed ID: 17372254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk.
    Baynes C; Healey CS; Pooley KA; Scollen S; Luben RN; Thompson DJ; Pharoah PD; Easton DF; Ponder BA; Dunning AM;
    Breast Cancer Res; 2007; 9(2):R27. PubMed ID: 17428325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CHEK2, MGMT, SULT1E1 and SULT1A1 polymorphisms and endometrial cancer risk.
    O'Mara TA; Ferguson K; Fahey P; Marquart L; Yang HP; Lissowska J; Chanock S; Garcia-Closas M; Thompson DJ; Healey CS; Dunning AM; Easton DF; ; Webb PM; Spurdle AB
    Twin Res Hum Genet; 2011 Aug; 14(4):328-32. PubMed ID: 21787115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Linkage disequilibrium mapping of CHEK2: common variation and breast cancer risk.
    Einarsdóttir K; Humphreys K; Bonnard C; Palmgren J; Iles MM; Sjölander A; Li Y; Chia KS; Liu ET; Hall P; Liu J; Wedrén S
    PLoS Med; 2006 Jun; 3(6):e168. PubMed ID: 16671833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The spectrum of ATM missense variants and their contribution to contralateral breast cancer.
    Broeks A; Braaf LM; Huseinovic A; Schmidt MK; Russell NS; van Leeuwen FE; Hogervorst FB; Van 't Veer LJ
    Breast Cancer Res Treat; 2008 Jan; 107(2):243-8. PubMed ID: 17393301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CHEK2 I157T and endometrial cancer.
    Konstantinova DV; Kadiyska TK; Kaneva RP; Tosheva EG; Guseva VT; Dimitrov BH; Dimitrov RG; Doganov NI; Ivanov SI; Kremensky IM; Mitev VI
    DNA Cell Biol; 2009 Jan; 28(1):9-12. PubMed ID: 18834326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.